Related Experiment Video
Updated: May 28, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Probiotic Fermentation Enhances Anti-Diabetic Effects of Chlorella pyrenoidosa in Mice by Modulating Gut Microbiota
Juntao Huang1,2, Yue Zhong1,2, Yang Wu1,2
1College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Abstract:
Numerous studies have demonstrated that Chlorella pyrenoidosa exerts potent anti-diabetic effects, yet its underlying mechanism remains elusive. Notably, no research has explored the anti-diabetic efficacy of its fermented product to date. In this study, we developed a novel compound probiotic-fermented C. pyrenoidosa product (CH-F), and systematically evaluated its anti-diabetic efficacy and mechanism. Furthermore, untargeted metabolomics analysis revealed that fermentation significantly altered the metabolite profile of C. pyrenoidosa, leading to the enrichment of potential anti-diabetic compounds such as acetylcholine and citicoline. In streptozotocin-induced T2DM mice, CH-F effectively ameliorated hyperglycemia, dyslipidemia, and hepatic/pancreatic histological injuries, showing markedly superior efficacy compared to unfermented C. pyrenoidosa. Additionally, CH-F modulated the gut microbiota and improved the levels of short-chain fatty acids (SCFAs) in the intestines of T2DM mice. We demonstrate that CH-F exerts anti-diabetic effects via gut microbiota modulation and SCFA regulation, highlighting its great potential as a functional food ingredient and dietary supplement for the adjuvant management of T2DM.
Related Concept Videos
Probiotics
Microbes in the Production of Fermented Foods
Microbes in Food Production
Dysbiosis of the Gut Microbiota
Functions of the Gut Microbiota
Microbiota Modulation by Antibiotics
